Six strains of Actinomadura pelletieri were shownto produce a designated MM46115. MM46115 was active against parainfluenza positive bacteria. Methods are described for the production of MM and for the isolation of the compound froma butanol extract of the culture filtrate.
During the course of a screening programme for microbial products with antiviral activity, a new antibiotic, designated MM461 15, was found to be produced by several strains of Actinomadura pelletieri. Spectroscopic data1" (will be reported separately) has revealed MM46115 to be a novel tetronic acid containing macrolide (Fig. 1) .
In this paper we describe the cultural characteristics of the producing strains, and the fermentation, isolation, physico-chemical and biological properties of the compound. The structure elucidation will be published elsewhere.
Materials and Methods

FermentationConditions
In order to study the fermentation of A. pelletieri in shake flasks, sterile water containing 0.025% Tween80 was added to glucose-yeast extract agar slope cultures to produce a vegetative mycelium fragment suspension (10ml per slope). Portions of this suspension (2.5ml) were used to inoculate 50ml of the seed stage medium (Arkasoy 0.9%, glucose 2.0%, pH 6.5) contained in 250-ml Erlenmeyer flasks closed with foam plastic bungs. The flasks were incubated for periods of between 144 and 216 hours at 26°C on a NewBrunswick G53 shaker at 240 rpm. The seed culture was added as a 3%inoculum to further 250-mi Erlenmeyer flasks each containing 50 ml of International Streptomyces Project 2 (ISP2) medium(yeast extract 0.4%, malt extract 1%, and glucose 0.4% prepared in deionised water and the pH adjusted to 7.3). The cultures were then grown (26°C, 240rpm) for periods of up to 192 hours.
For the production of MM46115 by strain IP 729.63 in fermenter vessels, the contents of 12 flasks containing the seed culture were combined and added as a 3% inoculum to a 15-liter Biolaffite in 
Fermentation Analyses
Mycelial growth was measured as packed cell volume (PCV) by centrifuging the fermentation broth at 5,000rpm for 35 minutes. Production of MM461 15 was determined by HPLCanalysis. A juBondapak C18 cartridge, 8 x 100 mm(Millipore, Watford, England) was used with a mobile phase of methanol -50 mM aqueous NH4OAc (3 : 1), pH 6.5. The flow rate was 2ml/minute. Duplicate shake flasks were harvested at 24 hour intervals. Samples of culture broth were removed, and 100 /il aliquots of culture filtrate (sterile filtered) were injected. The eluate was monitored at 280nm.The size of the absorbance peak due to MM 461 15, produced by the samples of culture filtrate and by a standard reference solution, was measured.
Antiviral and Cytotoxicity Assays Antiviral activity was determined against herpes simplex virus 1 in MRC-5cells (human diploid lung), influenza A virus and parainfluenza virus 1 (Sendai strain) in MDCKcells (Madin and Darby canine kidney), human parainfluenza viruses 2 and 3 and mumpsvirus in Vero cells (African Green Monkey kidney), respiratory syncytial virus strain A2 and 8/60 in HEp-2 cells (human epidermoid carcinoma of the larynx), visna virus strain K184 in SCPcells (sheep choroid plexus) and human immunodeficiency virus-1 in human peripheral blood lymphocytes.
Eight three-fold dilutions of MM461 15 (100 to 0.05 /ig/ml) were tested for antiviral activity against virus infected cells, and/or for cytotoxicity both by visual assessment of uninfected cells and by inhibition of [3H]thymidine incorporation. Cytotoxicity was also determined against mouse L1210 tumour cells.
Antifungal Assays
Solutions of MM46115 at 500 and 100/ig/ml were added to wells cut in agar plates seeded with Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae, Aspergillus niger, Hendersonula toruloidea, Paecilomyces varioti, Rhizopus oryzae and Trichophyton mentagrophytes. Following overnight incubation, at 37°C for the yeasts and 30°C for the filamentous fungi, activity was assessed by measuring zones of inhibition. Additionally a 50jug/ml solution was tested for its ability to prevent morphological transformation (i.e. germination and hyphal elongation) of C. albicans after 6 or 24 hours.
Antibacterial Assay
MICs were determined by a 2-fold microplate method. Todd-Hewitt broth (Oxoid) was used for Streptococcus sp. and Nutrient broth (Oxoid No. 2) was used for all other organisms. Final inoculation level was approximately 105 cfu perml.
Anthelmintic Assay
A solution of MM46115 in methanol was serially diluted in microwell plates to give replicate concentrations from 200 to 0.2/zg/ml. The solvent was removed by evaporation, then 100/zl suspensions ofnematodes added and the plates incubated overnight. The effect ofMM461 1 5 on mortality ofHaemonchus contortus L3 larvae and Turbatrix aceti or the prevention of Haemonchus egg hatch was determined by examination under a low power microscope.
Results
Cultural Characteristics A metabolite, designated MM461 1 5, with activity against the Sendai strain of parainfluenza virus type 1, was detected in culture extracts from the six strains of A. pelletieri listed in Table 1 . The highest levels of MM46115 were observed with strain IP 729.63. This culture was used to produce the compoundfor Table 1 .
Fermentation A typical time course of the fermentation of strain IP 729.63 in a 250-ml Erlenmeyer shake flask is shown in Fig. 2. A maximum titre of4.7~4.9^g/ml ofMM46115 was achieved after 168 hours. In order to produce sufficient quantities of MM461 1 5 to determine the properties and structure of the compound, strain IP 729.63 was grown in two 75-liter fermenters at 26°C for 168 hours.
Isolation
Fermentation broth (75 liters) was mixed with 25 liters of water. The diluted culture broth was clarified in an Westfalia CSA19disc-stack centrifuge and then passed through a 0.2 micron nylon membranefilter. The diluted culture filtrate (60 liters) was adjusted to pH 2.0, and then extracted with 40 liters butanol. The butanol layer (33 liters) was recovered. Fig. 3 outlines the procedures used to isolate MM46115, from the butanol extract to the crystalline product.
Physico-chemical Properties
The physico-chemical properties of MM461 15 are summarised in Table 2 .
Biological Properties MM461 15 was active against influenza A virus, parainfluenza virus 1 and 2 and respiratory syncytial virus strains A2 and 8/60 (Table 3) . However, significant antiviral activity in the absence of cytotoxicity was only seen against parainfluenza virus 1 and 2 at 0.046 and 0.1^g/ml. The ratio of antiviral activity to cytotoxicity was 9-and 10-fold, respectively. By comparison in these assays the positive control, ribavirin (l/?-D-ribofuranosyl-l,2,4 triazole-3-carboxamide) was active at 5.05 fig/ml against parainfluenza virus 1 and at 13.5^g/ml against parainfluenza virus 2. Cytotoxicity, as assessed by inhibition of [3H]thymidine incorporation ranged from 0.33 jUg/ml in MRC-5 cells to 0.78/ig/ml in SCP cells (Table  3 ). The concentration of MM461 15 giving 50% inhibition of mouse L1210 tumour cells was 0.65/ig/ml compared to 0.043 jug/ml with the positive control 5-fluorouracil. By comparing this figure with those given in Table 3 MM46115 showed no selectivity towards these tumour cells. MR:Multi-resistant (methicillin-, tetracycline-, erythromycin-and gentamycin-resistant).
MM461 15 showed slight inhibition of growth of both H. toruloidea and T. mentagrophytes. MM461 15 was inactive against Gram-negative organisms but inhibited all of the Gram-positive organisms with MICs ranging from 0.06/xg/ml for C. xerosis NCTC9755 to 1 jig/ml for S. saprophyticus FL1 ( Table 4 ). The activity against Gram-positive organisms compared favourably with vancomycin, where MICs varied between 0.5 and 4 /zg/ml for these organisms.
No activity was detected against any of the nematode species.
Discussion
All six of the A. pelletieri strains investigated have been shown to produce MM461 15. In contrast, antiviral activity was not detected in culture extracts of other species of Actinomadura, namely A. madurae, A. citrea, A. spadix, A. roseoviolacea, and A. pusilla, when they were grown under the same conditions. Our studies to date would suggest therefore that the production of MM 461 15 is a characteristic property of A. pelletieri. MM461 15 inhibited the replication of both parainfluenza virus 1 and 2 at concentrations that were not inhibitory to uninfected cells. Therapeutic ratios of between nine and ten were achieved. In these antiviral assays the activity of MM461 15 compared favourably with that of the positive control ribavirin. In contrast, no significant activity was seen against a range of other viruses. In addition, good activity has been observed against Gram-positive bacteria. However, MM461 15 failed to show any significant activity in the antifungal or anthelmintic assays.
Structural determinations have shown that MM46115 is related to kijanimicin obtained from Actinomadura kijaniata4rt 5) and to the tetrocarcin/antlermicin family of antibiotics from Micromonospora chalcea.6" 1^These compoundshave been shownto exhibit activity against Gram-positive bacteria and to be antitumour agents in mice. In addition kijanimicin has been found to be effective against malaria in mice. Unlike MM46115 they have not been reported to have antiviral properties. Our results are in agreement with the activity against Gram-positive bacteria but only moderate antitumour activity was detected in the L1210 assay. Further work is planned to determine the activity of MM461 15 in an animal model and will be reported in the future.
